Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Methotrexate | 0.0016596 | uM | 3 | 312.50 | 136.54 | 334.00 | 331.75 | 1.0068 | 1.0106 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 388.00 | 331.75 | 1.1696 | 1.2602 | |
| BT-20 | Taxol | 0.31623 | uM | 3 | 312.50 | 136.54 | 115.00 | 331.75 | 0.3467 | -0.1255 |
| BT-20 | Palbociclib | 0.01 | uM | 3 | 312.50 | 136.54 | 266.00 | 331.75 | 0.8018 | 0.6832 |
| BT-20 | Taxol | 1 | uM | 3 | 312.50 | 136.54 | 120.00 | 331.75 | 0.3617 | -0.0959 |
| BT-20 | Taxol | 0.0031623 | uM | 3 | 312.50 | 136.54 | 336.00 | 331.75 | 1.0128 | 1.0200 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 360.00 | 331.75 | 1.0852 | 1.1318 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 316.00 | 331.75 | 0.9525 | 0.9255 | |
| BT-20 | Palbociclib | 0.031623 | uM | 3 | 312.50 | 136.54 | 260.00 | 331.75 | 0.7837 | 0.6535 |
| BT-20 | Methotrexate | 0.0033113 | uM | 3 | 312.50 | 136.54 | 429.00 | 331.75 | 1.2931 | 1.4446 |
| BT-20 | Methotrexate | 1 | uM | 3 | 312.50 | 136.54 | 347.00 | 331.75 | 1.0460 | 1.0714 |
| BT-20 | Omipalisib | 0.1 | uM | 3 | 312.50 | 136.54 | 92.00 | 331.75 | 0.2773 | -0.2653 |
| BT-20 | Taxol | 0.001 | uM | 3 | 312.50 | 136.54 | 406.00 | 331.75 | 1.2238 | 1.3416 |
| BT-20 | Omipalisib | 0.31623 | uM | 3 | 312.50 | 136.54 | 131.00 | 331.75 | 0.3949 | -0.0318 |
| BT-20 | Omipalisib | 0.031623 | uM | 3 | 312.50 | 136.54 | 175.00 | 331.75 | 0.5275 | 0.2138 |
| BT-20 | Methotrexate | 10 | uM | 3 | 312.50 | 136.54 | 330.00 | 331.75 | 0.9947 | 0.9918 |
| BT-20 | Omipalisib | 0.01 | uM | 3 | 312.50 | 136.54 | 239.00 | 331.75 | 0.7204 | 0.5482 |
| BT-20 | Omipalisib | 3.1623 | uM | 3 | 312.50 | 136.54 | 80.00 | 331.75 | 0.2412 | -0.3413 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 300.00 | 331.75 | 0.9043 | 0.8489 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 244.00 | 331.75 | 0.7355 | 0.5735 | |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 613.00 | 571.50 | 1.0726 | 1.1398 | |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 618.00 | 571.50 | 1.0814 | 1.1566 | |
| BT-20 | Methotrexate | 0.031623 | uM | 3 | 625.00 | 278.42 | 659.00 | 571.50 | 1.1531 | 1.2944 |
| BT-20 | Omipalisib | 1 | uM | 3 | 625.00 | 278.42 | 111.00 | 571.50 | 0.1942 | -0.5878 |
| BT-20 | Methotrexate | 0.1 | uM | 3 | 625.00 | 278.42 | 609.00 | 571.50 | 1.0656 | 1.1263 |